VICTORY CAPITAL MANAGEMENT INC

Position in ERAS — Erasca, Inc.

CIK 1040188 San Antonio, TX

Position in ERAS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$26,769,761

+$26,701,347 QoQ

Shares Held

1,654,497

+8896.2% QoQ

Ownership

0.532%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,018,555,898 across 156 Biotechnology names. ERAS ranks #11 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,888,521	$843,300,167
2	RPRX	Royalty Pharma plc	3,853,808	$184,867,169
3	INCY	Incyte Corp	1,742,870	$164,038,924
4	REGN	Regeneron Pharmaceuticals, Inc.	129,074	$99,727,735
5	ALNY	Alnylam Pharmaceuticals, Inc.	195,937	$64,829,675
6	INSM	INSMED Inc	396,245	$64,793,982
7	LGND	Ligand Pharmaceuticals Inc	303,224	$60,538,671
8	JAZZ	Jazz Pharmaceuticals plc	256,598	$48,509,851

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$26,769,761	1,654,497	+8896.2%	Shares	Sole	2026-05-15
2025-12-31	$68,414	18,391	-0.8%	Shares	Sole	2026-02-13
2025-09-30	$40,399	18,532	-3.2%	Shares	Sole	2025-11-12
2025-06-30	$24,321	19,151	-2.8%	Shares	Sole	2025-08-13
2025-03-31	$27,002	19,710	-2.5%	Shares	Sole	2025-05-02
2024-12-31	$50,742	20,216	-4.1%	Shares	Sole	2025-02-06
2024-09-30	$57,545	21,079	-1.9%	Shares	Sole	2024-11-05
2024-06-30	$50,690	21,479	+82.2%	Shares	Sole	2024-08-05
2024-03-31	$24,287	11,790	-6.5%	Shares	Sole	2024-05-03
2023-12-31	$26,872	12,616	+24.6%	Shares	Sole	2024-02-05
2023-09-30	$19,946	10,125	—	Shares	Sole	2023-11-06
No filing history on record for this holder in this stock.